AURORA US is a clinical study for metastatic breast cancer patients.
Aurora US is a clinical study, not a treatment trial, that will collect biospecimens from patient volunteers who have received a diagnosis of metastatic breast cancer after having been treated for early stage breast cancer.
Metastatic breast cancer is currently incurable. In order to better understand how and why breast cancers spread and to develop better treatments for patients diagnosed with MBC, researchers will perform analyses on samples of primary (original) and metastatic tumors and combine this with treatment information from participants. The findings of this study may help future patients with metastatic breast cancer.
This study is funded by the Evelyn H. Lauder Founder’s Fund for Metastatic Breast Cancer Research established by the Breast Cancer Research Foundation (BCRF).
AURORA US is part of a larger initiative funded by the Breast Cancer Research Foundation (BCRF) to find solutions to breast cancer metastasis. This unprecedented effort, named collectively the BCRF Metastatic Breast Cancer Collaborative, brings together researchers from around the world to tackle the biggest challenge in breast cancer. Learn more at BCRF.org.
“We’ve amassed scientists from all over the world to look for what we can address to stop metastases and deaths from breast cancer. We’ve discovered some very important things already, and as we progress with the BCRF AURORA project I think we’re going to get to the end of cancer.”
Larry Norton, MD
Senior Vice President, Memorial Sloan Kettering Cancer Center
Founding Scientific Director, Breast Cancer Research Foundation
The mission of the Breast Cancer Research Foundation is to prevent and cure breast cancer by advancing the world’s most promising research.
The Translational Breast Cancer Research Consortium is a collaborative group founded to conduct innovative and high-impact clinical trials for breast cancer.